Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment.
about
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerTransient appearance of circulating tumor DNA associated with de novo treatment.Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.Automated DNA extraction using cellulose magnetic beads can improve EGFR point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments.
P2860
Early responses of EGFR circulating tumor DNA to EGFR tyrosine kinase inhibitors in lung cancer treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early responses of EGFR circul ...... tors in lung cancer treatment.
@en
Early responses of EGFR circul ...... tors in lung cancer treatment.
@nl
type
label
Early responses of EGFR circul ...... tors in lung cancer treatment.
@en
Early responses of EGFR circul ...... tors in lung cancer treatment.
@nl
prefLabel
Early responses of EGFR circul ...... tors in lung cancer treatment.
@en
Early responses of EGFR circul ...... tors in lung cancer treatment.
@nl
P2093
P2860
P356
P1433
P1476
Early responses of EGFR circul ...... tors in lung cancer treatment.
@en
P2093
Fumio Imamura
Junji Uchida
Kazumi Nishino
Kikuya Kato
Madoka Kimura
Takako Inoue
Toru Kumagai
Yoji Kukita
P2860
P304
71782-71789
P356
10.18632/ONCOTARGET.12373
P407
P577
2016-09-30T00:00:00Z